Clinical Trials Directory

Trials / Unknown

UnknownNCT02610595

Study on the Therapeutic Effect of TCM Treatment for MDR MN

A Prospective, Multi-center Study of the Chinese Medicine for the Treatment of MDR Membranous Nephropathy in the Traditional Chinese Medicine (a Herbal Formula for Invigorating Spleen and Benefiting qi and Promoting Blood Circulation)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Shanghai University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effectiveness and safety of the Chinese medicine treatment for multiple drug resistance of MN patients with Jianpiyiqi and Huoxuejiedu Recipe.

Detailed description

Based on previous research, the investigators hoping to identity the standard treatment program for MDR IMN patients with high treatment difficulty, TCM syndrome of s Pixushuifan. Subsequently, to evaluate the effectiveness and safety of the Chinese medicine treatment for multiple drug resistance of MN patients with Jianpiyiqi and Huoxuejiedu Recipe. With twenty national-grade III hospital of to formed TCM Comprehensive treatment plan and to evaluate the effectiveness and safety of the Chinese medicine treatment for multiple drug resistance of MN patients with Jianpiyiqi and Huoxuejiedu Recipe. Furthermore, search for potential diagnostic predictor in IMN by Proteomics and Metabolomics. The investigators purpose is improve the clinical remission rate of MN, further establish the treatment of TCM in the treatment of MN.

Conditions

Interventions

TypeNameDescription
DRUGJianpixiaozhong particles and Wuse DietotherapyJianpixiaozhong particles: Three packs once,bid po; Wuse Dietotherapy: one packs once,bid po

Timeline

Start date
2015-12-01
Primary completion
2016-06-01
Completion
2016-12-01
First posted
2015-11-20
Last updated
2015-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02610595. Inclusion in this directory is not an endorsement.